An official website of the United States government
September 29, 2026 Edition
News
Antiviral drug did not improve Long COVID symptoms
A clinical trial for Long COVID found that treating patients with a common antiviral drug for up to 25 days did not improve symptoms.
News
tRNA treatment may help restore cystic fibrosis proteins
Lipid nanoparticles delivering engineered transfer RNA restored functional proteins in cell and animal models of cystic fibrosis.
News
Bacterial infection may alter developing gut
C. difficile bacteria caused lasting changes to cells in the intestines of newborn mice.
Displaying 225 - 231 of 912
Altered brain connections in youth with ADHD
Youth with ADHD have elevated brain activity connecting the frontal cortex with the information processing centers deep in the brain.
Weight-loss surgery yields long-term benefits for type 2 diabetes
Bariatric surgery helped people with type 2 diabetes better control their blood glucose years later compared to medical and lifestyle interventions.
Designing a new antibiotic to combat drug resistance
Researchers designed a synthetic drug that shuts down protein production in a range of different bacteria.
Talk therapy cuts risk of postpartum depression
An intervention given to pregnant women by non-specialist providers greatly reduced the chances of developing postpartum depression or anxiety.
How excess niacin may promote cardiovascular disease
Findings about a metabolite of niacin, or vitamin B3, raise concerns about the health effects of too much niacin and suggest new measures to help prevent or treat cardiovascular disease
Drug cuts risk of allergic reactions to peanuts and other foods
Researchers showed that a drug used to treat allergic asthma can reduce reactions to peanuts and other common foods in children with multiple food allergies.
Insight into mechanisms of ME/CFS
Researchers compared people with post-infectious ME/CFS to those without and found important differences in their brains and other body systems.